![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Terminated |
Unique ID issued by UMIN | UMIN000005068 |
Receipt No. | R000006025 |
Scientific Title | The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients |
Date of disclosure of the study information | 2011/02/10 |
Last modified on | 2014/04/04 |
Basic information | ||
Public title | The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients | |
Acronym | The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients | |
Scientific Title | The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients | |
Scientific Title:Acronym | The effect of Darbepoetin for renal anemia and iron kinetics in Chronic Kidney Disease(CKD) patients | |
Region |
|
Condition | ||
Condition | Chronic kidney disease and renal anemia | |
Classification by specialty |
|
|
Classification by malignancy | Others | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | The effect of Darbepoetin for renal anemia in CKD patients |
Basic objectives2 | Safety,Efficacy |
Basic objectives -Others | |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | The mean hemoglobin(Hb) change and the achievement rate of Hb target concentration |
Key secondary outcomes | Iron kinetics |
Base | |
Study type | Interventional |
Study design | |
Basic design | Cross-over |
Randomization | Randomized |
Randomization unit | |
Blinding | Open -no one is blinded |
Control | Active |
Stratification | NO |
Dynamic allocation | NO |
Institution consideration | |
Blocking | |
Concealment |
Intervention | ||
No. of arms | 2 | |
Purpose of intervention | Treatment | |
Type of intervention |
|
|
Interventions/Control_1 | Epoetin | |
Interventions/Control_2 | Darbepoetin | |
Interventions/Control_3 | ||
Interventions/Control_4 | ||
Interventions/Control_5 | ||
Interventions/Control_6 | ||
Interventions/Control_7 | ||
Interventions/Control_8 | ||
Interventions/Control_9 | ||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | The concentration of Hb is under 11.0mg/dl in CKD patients
|
|||
Key exclusion criteria | severe heart failure
impossible control of hypertension and so on |
|||
Target sample size | 20 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Yamamoto General Hospital | ||||||
Division name | Internal Medicine | ||||||
Zip code | |||||||
Address | 3-11 Kotobuki-cho Kuwana city Mie prefecture | ||||||
TEL | 059221211 | ||||||
takayassu@msn.com |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Yamamoto general hospital | ||||||
Division name | Internal Medicine | ||||||
Zip code | |||||||
Address | 3-11 Kotobuki-cho Kuwana city Mie prefecture | ||||||
TEL | 0594221211 | ||||||
Homepage URL | |||||||
takayassu@msn.com |
Sponsor | |
Institute | Yamamoto General Hospital |
Institute | |
Department |
Funding Source | |
Organization | Yamamoto General Hospital |
Organization | |
Division | |
Category of Funding Organization | Self funding |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | |
Address | |
Tel | |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Terminated | ||||||
Date of protocol fixation |
|
||||||
Date of IRB | |||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry |
|
||||||
Date trial data considered complete |
|
||||||
Date analysis concluded |
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006025 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |